8-K
filed January 23, 2025, 6:59 PM ET
ticker IDAI
CIK 0001718939
regulatory
confidence high
sentiment neutral
materiality 0.55
T Stamp regains compliance with Nasdaq $1.00 minimum bid price rule
T Stamp Inc
- Received Nasdaq notice on Jan 23, 2025 confirming compliance with Listing Rule 5550(a)(2).
- Company maintained bid price of $1.00 or greater for 11 consecutive business days (Jan 6-22, 2025).
- Previously disclosed bid price deficiency letters from May 3 and Nov 5, 2024; matter now closed.
- Regaining compliance removes delisting risk from Nasdaq Capital Market.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001718939-25-000019
- form_type
- 8-K
- ticker
- IDAI
- cik
- 0001718939
- company_name
- T Stamp Inc
- filed_at
- 2025-01-23T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:04.576326+00:00
- generated_at
- 2026-05-27T14:50:06.907574+00:00
- sec_items
- ["8.01"]
- event_type
- regulatory
- sentiment
- neutral
- materiality_score
- 0.55
- calibrated_materiality_score
- 0.55
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001718939-25-000019
- json_url
- https://secwatch.observer/filing/0001718939-25-000019.json
- markdown_url
- https://secwatch.observer/filing/0001718939-25-000019.md
- text_url
- https://secwatch.observer/filing/0001718939-25-000019.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1718939/000171893925000019/0001718939-25-000019-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1718939/000171893925000019/idai-20250123.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
PDSB
PDS Biotech regains Nasdaq minimum bid price compliance as of June 2, 2026
PDS Biotechnology Corp
June 2, 2026, 3:35 PM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
TXNM
TXNM subsidiaries: TNMP rate settlement with $20.5M storm rider, PNM resource plan with 1.65 GW renewables
TXNM ENERGY INC
June 1, 2026, 5:54 PM ET
regulatory
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
LESL
Leslie's regains Nasdaq compliance for minimum market value of publicly held shares
Leslie's, Inc.
June 1, 2026, 4:28 PM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
RICK
RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q
RCI HOSPITALITY HOLDINGS, INC.
June 1, 2026, 3:08 PM ET
regulatory
Items 8.01, 9.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
VYGR
FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's
Voyager Therapeutics, Inc.
June 1, 2026, 8:00 AM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
EXFY
Expensify regains Nasdaq minimum bid price compliance
Expensify, Inc.
May 29, 2026, 5:15 PM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
SLXN
Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted
Silexion Therapeutics Corp
May 29, 2026, 7:00 AM ET
regulatory
Items 3.03, 5.03, 8.01, 9.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
MNKD
FDA releases MannKind from Afrezza malignancy study; sBLA for children PDUFA May 29
MANNKIND CORP
May 28, 2026, 8:37 AM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.